Login Register Cart 0
Generic placeholder image

Current Indian Science

Editor-in-Chief

ISSN (Print): 2210-299X
ISSN (Online): 2210-3007

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Review Article

Quinazolinone: Pharmacophore with Endless Pharmacological Actions

Author(s): Meenakshi Dhanawat*, Sumeet Gupta and Somdutt Mujwar

Volume 1, 2023

Published on: 25 January, 2023

Article ID: e251122211243 Pages: 22

DOI: 10.2174/2210299X02666221125101550

Price: $

Abstract

Due to its extensive applications in the field of pharmaceutical chemistry and its potent biological and pharmacological activities, including analgesic, antioxidant, antimicrobial, anticancer, ant-inflammatory, anti-tubercular, antihyperlipidemic, antihistamine, antiviral, anticonvulsant and antiparkinsonian, the heterocyclic molecule occupies a distinct place in the scientific community. The discovery that many synthetic quinazolinone derivatives exhibit a wide range of biological functions has sparked interest in this area of study.

The purpose of this review is to collate literature work reported by researchers on quinazolinone and its derivatives for their various pharmacological activities.

[1]
Abbas, S.E.; Barsoum, F.F.; Georgey, H.H.; Mohammed, E.R. Synthesis and antitumor activity of certain 2,3,6-trisubstituted quinazolin-4(3H)-one derivatives. Bull. Fac. Pharm. Cairo Univ., 2013, 51(2), 273-282.
[http://dx.doi.org/10.1016/j.bfopcu.2013.08.003]
[2]
Banu, B.H.; Bharathi, K.; Prasad, K.V. Synthesis, characterization and evaluation of in vitro antioxidant and anti-inflammatory activity of 2-(4-oxo-2-phenylquinazolin-3(4H)-yl) substituted acetic acids. IOSR J. Pharm., 2012, 2(1), 97-104.
[http://dx.doi.org/10.9790/3013-021097104]
[3]
Faraj, F.L.; Zahedifard, M.; Paydar, M.; Looi, C.Y.; Abdul Majid, N.; Ali, H.M.; Ahmad, N.; Gwaram, N.S.; Abdulla, M.A. Synthesis, characterization, and anticancer activity of new quinazoline derivatives against MCF-7 cells. ScientificWorldJournal, 2014, 2014, 1-15.
[http://dx.doi.org/10.1155/2014/212096] [PMID: 25548779]
[4]
Arora, R.; Kapoor, A.; Gill, N.S.; Rana, A.C. Quinazolinone: An overview. Int. Res. J. Pharm., 2011, 2, 21-28.
[5]
Saad, H.A.; Osman, N.A.; Moustafa, A.H. Synthesis and analgesic activity of some new pyrazoles and triazoles bearing a 6,8-dibromo-2-methylquinazoline moiety. Molecules, 2011, 16(12), 10187-10201.
[http://dx.doi.org/10.3390/molecules161210187] [PMID: 22157581]
[6]
Priya, M.G.; Girija, K.; Ravichandran, N. In vitro study of anti-inflammatory and antioxidant activity of 4-(3H)-quinazolinone derivatives. Rasayan J. Chem., 2011, 4, 418-424.
[7]
Rakesh, K.P.; Manukumar, H.M.; Gowda, D.C. Schiff’s bases of quinazolinone derivatives: Synthesis and SAR studies of a novel series of potential anti-inflammatory and antioxidants. Bioorg. Med. Chem. Lett., 2015, 25(5), 1072-1077.
[http://dx.doi.org/10.1016/j.bmcl.2015.01.010] [PMID: 25638040]
[8]
Patel, D.R.; Patel, K.C. Synthesis, characterization and in vitro antimicrobial screening of some new MCT reactive dyes bearing nitro quinazolinone moiety. J. Saudi Chem. Soc., 2015, 19(4), 347-359.
[http://dx.doi.org/10.1016/j.jscs.2012.02.002]
[9]
Khodarahmi, G.; Jafari, E.; Hakimelahi, G.; Abedi, D.; Rahmani Khajouei, M.; Hassanzadeh, F. Synthesis of some new quinazolinone derivatives and evaluation of their antimicrobial activities. Iran. J. Pharm. Res., 2012, 11(3), 789-797.
[PMID: 24250506]
[10]
Wang, D.; Gao, F. Quinazoline derivatives: Synthesis and bioactivities. Chem. Cent. J., 2013, 7(1), 95.
[http://dx.doi.org/10.1186/1752-153X-7-95] [PMID: 23731671]
[11]
Kumar, D.; Mariappan, G.; Husain, A.; Monga, J.; Kumar, S. Design, synthesis and cytotoxic evaluation of novel imidazolone fused quinazolinone derivatives. Arab. J. Chem., 2017, 10(3), 344-350.
[http://dx.doi.org/10.1016/j.arabjc.2014.07.001]
[12]
Keche, A.P.; Kamble, V.M. Synthesis and anti-inflammatory and antimicrobial activities of some novel 2-methylquinazolin-4(3H)-one derivatives bearing urea, thiourea and sulphonamide functionalities. Arab. J. Chem., 2019, 12(7), 1522-1531.
[http://dx.doi.org/10.1016/j.arabjc.2014.10.025]
[13]
F Zayed, M.; H Hassan, M. Synthesis and biological evaluation studies of novel quinazolinone derivatives as antibacterial and anti-inflammatory agents. Saudi Pharm. J., 2014, 22(2), 157-162.
[http://dx.doi.org/10.1016/j.jsps.2013.03.004] [PMID: 24648828]
[14]
Devi, K.; Kachroo, M. Synthesis and anti-tubercular activity of some new 2, 3-disubstituted quinazolinones. Pharma Chem., 2014, 6, 353-359.
[15]
Refaie, F.M.; Esmat, A.Y.; Gawad, S.M.A.; Ibrahim, A.M.; Mohamed, M.A. The antihyperlipidemic activities of 4(3H) quinazolinone and two halogenated derivatives in rats. Lipids Health Dis., 2005, 4(1), 22.
[http://dx.doi.org/10.1186/1476-511X-4-22] [PMID: 16202158]
[16]
Gobinath, M.; Subramanian, N.; Alagarsamy, V. Design, synthesis and H1-antihistaminic activity of novel 1-substituted-4-(3-chlorophenyl)-[1,2,4] triazolo [4,3-a] quinazolin-5(4H)-ones. J. Saudi Chem. Soc., 2015, 19(3), 282-286.
[http://dx.doi.org/10.1016/j.jscs.2012.02.006]
[17]
Gulick, R.M. New antiretroviral drugs. Clin. Microbiol. Infect., 2003, 9(3), 186-193.
[http://dx.doi.org/10.1046/j.1469-0691.2003.00570.x] [PMID: 12667250]
[18]
Laddha, S.S.; Bhatnagar, S.P. Novel fused quinazolinones: Further studies on the anticonvulsant activity of 1,2,9,11-tetrasubstituted7Hthieno [2́,3́:4,5] pyrimido [6,1b]-quinazolin-7-one and 1,3,10,12-tetrasubstituted-8H-pyrido [2́,3́:4,5] pyrimido [6,1b] quinazolin-8-one. Future Med. Chem., 2010, 2, 565-573.
[http://dx.doi.org/10.4155/fmc.10.16] [PMID: 21426007]
[19]
Kumar, S.; Kaur, H.; Kumar, A. Synthesis of new azetidinonyl/thiazolidinonyl quinazolinone derivatives as antiparkinsonian agents. Arab. J. Chem., 2012, 5(4), 475-484.
[http://dx.doi.org/10.1016/j.arabjc.2010.09.014]
[20]
Al-Rashood, S.T.; Aboldahab, I.A.; Nagi, M.N.; Abouzeid, L.A.; Abdel-Aziz, A.A.M.; Abdel-hamide, S.G.; Youssef, K.M.; Al-Obaid, A.M.; El-Subbagh, H.I. Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs. Bioorg. Med. Chem., 2006, 14(24), 8608-8621.
[http://dx.doi.org/10.1016/j.bmc.2006.08.030] [PMID: 16971132]
[21]
Liu, S.; Liu, F.; Yu, X.; Ding, G.; Xu, P.; Cao, J.; Jiang, Y. The 3D-QSAR analysis of 4(3H)-quinazolinone derivatives with dithiocarbamate side chains on thymidylate synthase. Bioorg. Med. Chem., 2006, 14(5), 1425-1430.
[http://dx.doi.org/10.1016/j.bmc.2005.09.064] [PMID: 16263296]
[22]
Hattori, K.; Kido, Y.; Yamamoto, H.; Ishida, J.; Iwashita, A.; Mihara, K. Rational design of conformationally restricted quinazolinone inhibitors of poly(ADP-ribose)polymerase. Bioorg. Med. Chem. Lett., 2007, 17(20), 5577-5581.
[http://dx.doi.org/10.1016/j.bmcl.2007.07.091] [PMID: 17804225]
[23]
Guiles, J.; Sun, X.; Critchley, I.A.; Ochsner, U.; Tregay, M.; Stone, K.; Bertino, J.; Green, L.; Sabin, R.; Dean, F.; Garry Dallmann, H.; McHenry, C.S.; Janjic, N. Quinazolin-2-ylamino-quinazolin-4-ols as novel non-nucleoside inhibitors of bacterial DNA polymerase III. Bioorg. Med. Chem. Lett., 2009, 19(3), 800-802.
[http://dx.doi.org/10.1016/j.bmcl.2008.12.038] [PMID: 19109016]
[24]
Orvieto, F.; Branca, D.; Giomini, C.; Jones, P.; Koch, U.; Ontoria, J.M.; Palumbi, M.C.; Rowley, M.; Toniatti, C.; Muraglia, E. Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors. Bioorg. Med. Chem. Lett., 2009, 19(15), 4196-4200.
[http://dx.doi.org/10.1016/j.bmcl.2009.05.113] [PMID: 19541484]
[25]
Khalil, A.A.; Abdel hamide, S.G.; Al-Obaid, A.M.; El-subbagh, H. Substituted quinazolinones, Part2. Synthesis and in vitro anticancer evaluation of new 2-substituted mercapto-3H-quinazolin analogs. Arch. Pharm. Pharm. Med. Chem., 2003, 336, 95-103.
[http://dx.doi.org/10.1002/ardp.200390011] [PMID: 12761762]
[26]
Nagar, A.A.; Rathi, L.G.; Chugh, N.; Pise, V.J.; Bendale, A. Microwave assisted one pot synthesis of 2, 3-di-substituted quinazolin-4- (3H)-ones and their potential biological activity. Pharma Chem., 2010, 2, 37-43.
[27]
Vane, J.R.; Botting, R.M. New insights into the mode of action of anti-inflammatory drugs. Inflamm. Res., 1995, 44(1), 1-10.
[http://dx.doi.org/10.1007/BF01630479] [PMID: 7664022]
[28]
van Ryn, J.; Trummlitz, G.; Pairet, M. COX-2 selectivity and inflammatory processes. Curr. Med. Chem., 2000, 7(11), 1145-1161.
[http://dx.doi.org/10.2174/0929867003374255] [PMID: 11032964]
[29]
Kumar, A.; Sharma, S.; Archana, K.; Bajaj, K.; Sharma, S.; Panwar, H.; Singh, T.; Srivastava, V.K. Some new 2,3,6-trisubstituted quinazolinones as potent anti-inflammatory, analgesic and COX-II inhibitors. Bioorg. Med. Chem., 2003, 11(23), 5293-5299.
[http://dx.doi.org/10.1016/S0968-0896(03)00501-7] [PMID: 14604693]
[30]
Alagarsamy, V.; Raja Solomon, V.; Dhanabal, K. Synthesis and pharmacological evaluation of some 3-phenyl-2-substituted-3H-quinazolin-4-one as analgesic, anti-inflammatory agents. Bioorg. Med. Chem., 2007, 15(1), 235-241.
[http://dx.doi.org/10.1016/j.bmc.2006.09.065] [PMID: 17079148]
[31]
Omar, A.; Fattah, M.F.; Emad, M.M.; Neama, M.I.; Mohsen, M.K. Synthesis of some new quinazolin-4-one derivatives and evaluation of their antimicrobial and anti-inflammatory effects. Acta Pol. Pharm.: Drug Res., 2008, 65, 11-20.
[32]
Srivastav, M.; Salahuddin, M.; Shantakumar, S.M. Synthesis and anti-inflammatory activity of some novel 3-(6-Substituted-1, 3-benzothiazole-2-yl)-2-[(4-substituted phenyl) amino methyl] quinazolines-4 (3 H )-ones. E-J. Chem., 2009, 6(4), 1055-1062.
[http://dx.doi.org/10.1155/2009/507052]
[33]
Giri, R.S.; Thaker, H.M.; Giordano, T.; Williams, J.; Rogers, D.; Sudersanam, V.; Vasu, K.K. Design, synthesis and characterization of novel 2-(2,4-disubstituted-thiazole-5-yl)-3-aryl-3H-quinazoline-4-one derivatives as inhibitors of NF-κB and AP-1 mediated transcription activation and as potential anti-inflammatory agents. Eur. J. Med. Chem., 2009, 44(5), 2184-2189.
[http://dx.doi.org/10.1016/j.ejmech.2008.10.031] [PMID: 19064304]
[34]
Rajver, C.H.; Swarnalatha, C.H.; Stephen, R. Synthesis of 6-bromooxo quinazoline derivatives and their pharmacological activities. Int. J. Chemtech Res., 2010, 1(1), 21-24.
[35]
Hemalatha, K.; Girija, K. Synthesis of some novel 2, 3¬ disubstituted quinazolinone derivatives as analgesic and anti-inflammatory agent. Int. J. Pharm. Pharm. Sci., 2011, 3, 1491.
[36]
Rajasekaran, A.; Rajamanickam, V.; Darlinquine, S. Synthesis, anti-inflammatory and analgesic evaluation of thioxoquinazolinone derivatives. Yakugaku Zasshi, 2011, 131(7), 1079-1084.
[http://dx.doi.org/10.1248/yakushi.131.1079] [PMID: 21720138]
[37]
Rajput, C.S.; Singhal, S. Synthesis, characterization, and anti-inflammatory activity of newer quinazolinone analogues. Int. J. Pharm., 2013, 2013, 907525.
[http://dx.doi.org/10.1155/2013/907525]
[38]
Ahmed, S.M.; Devidas, U.C. Anti-allodynic effects of a novel quinazolin-4(3H)- ones derivative: 2-(2-methyl-4-oxoquinazolin3(4H)-yl)-N-p-tolylacetamide (P-TOL) in CCI and SNL induced neuropathic pain in rats. Int. J. Sci. Eng. Res., 2013, 4, 2602-2606.
[39]
Abdel-Aziz, A.A.M.; Abou-Zeid, L.A.; ElTahir, K.E.H.; Mohamed, M.A.; Abu El-Enin, M.A.; El-Azab, A.S. Design, synthesis of 2,3-disubstitued 4(3H)-quinazolinone derivatives as anti-inflammatory and analgesic agents: COX-1/2 inhibitory activities and molecular docking studies. Bioorg. Med. Chem., 2016, 24(16), 3818-3828.
[http://dx.doi.org/10.1016/j.bmc.2016.06.026] [PMID: 27344214]
[40]
Poojari, S.; Naik, P.P.; Krishnamurthy, G.; Kumara K.S, J.; Kumar N, S.; Naik, S. Anti-inflammatory, antibacterial and molecular docking studies of novel spiro-piperidine quinazolinone derivatives. J. Taibah Univ. Sci., 2017, 11, 497-511.
[http://dx.doi.org/10.1016/j.jtusci.2016.10.003]
[41]
El-Feky, S.A.; Imran, M.; Nayeem, N. Design, synthesis, and anti-inflammatory activity of novel quinazolines. Orient. J. Chem., 2017, 33, 707-716.
[http://dx.doi.org/10.13005/ojc/330217]
[42]
Mohamed, M.A.; Ghanem, H.M.; Abd El-Ghaffar, N.F.; Mohamed, S.S. Biological evaluation and molecular docking of substituted quinazolinones as antimicrobial agents. Aust. J. Basic Appl. Sci., 2013, 7, 263-274.
[43]
Jatav, V.; Kashaw, S.; Mishra, P. Synthesis, antibacterial and antifungal activity of some novel 3-[5-(4-substituted phenyl) 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones. Med. Chem. Res., 2008, 17(2-7), 169-181.
[http://dx.doi.org/10.1007/s00044-007-9047-2]
[44]
Kohli, D.; Hashim, R.; Vishal, S.; Sharma, M.; Singh, A.K. Synthesis and antibacterial activity of quinazolinone derivatives. Int. J. Pharm. Pharm. Sci., 2009, 163-169.
[45]
Patel, N.B.; Patel, J.C. Synthesis and antimicrobial activity of Schiff bases and 2-azetidinones derived from quinazolin-4(3H)-one. Arab. J. Chem., 2011, 4(4), 403-411.
[http://dx.doi.org/10.1016/j.arabjc.2010.07.005]
[46]
Kumar, A.; Sharma, P.; Kumari, P.; Lal Kalal, B. Exploration of antimicrobial and antioxidant potential of newly synthesized 2,3-disubstituted quinazoline-4(3H)-ones. Bioorg. Med. Chem. Lett., 2011, 21(14), 4353-4357.
[http://dx.doi.org/10.1016/j.bmcl.2011.05.031] [PMID: 21658941]
[47]
Suresha, G.P.; Suhas, R.; Kapfo, W.; Channe Gowda, D. Urea/thiourea derivatives of quinazolinone–lysine conjugates: Synthesis and structure–activity relationships of a new series of antimicrobials. Eur. J. Med. Chem., 2011, 46(6), 2530-2540.
[http://dx.doi.org/10.1016/j.ejmech.2011.03.041] [PMID: 21481990]
[48]
Alafeefy, A.M.; El-Azab, A.S.; Mohamed, M.A.; Bakhat, M.A.; Abdel-Hamid, S.G. Synthesis of some new substituted iodoquinazoline derivatives and their antimicrobial screening. J. Saudi Chem. Soc., 2011, 15(4), 319-325.
[http://dx.doi.org/10.1016/j.jscs.2011.07.005]
[49]
Mujalda, V.; Tiwari, S.; Sharma, V.; Saxena, P.; Shrivastava, M. Synthesis and antimicrobial evaluation of some new quinazoline based thiosemicarbazones. Int. J. Chemtech Res., 2012, 4, 1033-1037.
[50]
Break, L.M.; Mosselhi, M.A.N. Synthesis, structure and antimicrobial activity of new 3- and 2- arylmethyl and arylacyl-3H[1,2,4]triazino[3,2-b]-quinazoline-2,6(1H)diones as expected as DNA fluorphores. Res. J. Chem. Sci., 2012, 2, 23-28.
[51]
Raval, J.P.; Desai, K.G.; Desai, K.R. Microwave synthesis, characterization and antimicrobial study of new pyrazolyl-oxopropylquinazolin-4(3H)-one derivatives. J. Saudi Chem. Soc., 2012, 16(4), 387-393.
[http://dx.doi.org/10.1016/j.jscs.2011.02.003]
[52]
Sojitra, N.A.; Dixit, R.B.; Patel, R.K.; Patel, J.B.; Dixit, B.C. Classical and microwave assisted synthesis of new 4-(3,5-dimethyl-1-phenyl-1H-pyrazol-4-ylazo)-N-(2-substituted-4-oxo-4H-quinazolin-3-yl) benzenesulfonamide derivatives and their antimicrobial activities. J. Saudi Chem. Soc., 2016, 20(S1), S29-S37.
[53]
Unnissa, S.H.; Reddy, G.K. Synthesis and antimicrobial screening of 3H-Quinazolin-4-ones containing 3-methyl pyrazolinone moiety. Curr. Pharma. Res., 2012, 3(1), 690-696.
[http://dx.doi.org/10.33786/JCPR.2012.v03i01.003]
[54]
Desai, N.C.; Dodiya, A.; Bhatt, N.; Kumar, M. Dimeric 2-(2-chlorophenyl)-quinazolin-4-ones as potential antimicrobial agents. Med. Chem. Res., 2012, 21(7), 1127-1135.
[http://dx.doi.org/10.1007/s00044-011-9621-5]
[55]
Jafari, E.; Khodarahmi, G.A.; Hakimelahi, G.H.; Tsai, F.Y.; Hassanzadeh, F. Synthesis of some new tricyclic 4(3H)-quinazolinone derivatives. Res. Pharm. Sci., 2011, 6(2), 93-100.
[PMID: 22224092]
[56]
Hassanzadeh, F.; Jafari, E.; Hakimelahi, G.H.; Khajouei, M.R.; Jalali, M.; Khodarahmi, G.A. Antibacterial, antifungal and cytotoxic evaluation of some new quinazolinone derivatives. Res. Pharm. Sci., 2012, 7(2), 87-94.
[PMID: 23181085]
[57]
Hassanzadeh, F.; Khajouei, M.R.; Hakimelahi, G.H.; Jafari, E.; Khodarahmi, G.A. Synthesis of some new 2,3-disubstituted-4(3H)quinazolinone derivatives. Res. Pharm. Sci., 2012, 7(1), 23-30.
[PMID: 23181076]
[58]
Khodarahmi, G.A.; Khajouei, M.R.; Hakimelahi, G.H.; Abedi, D.; Jafari, E.; Hassanzadeh, F. Antibacterial, antifungal and cytotoxic evaluation of some new 2,3-disubstituted 4(3H)-quinazolinone derivatives. Res. Pharm. Sci., 2012, 7(3), 151-158.
[PMID: 23181093]
[59]
Dave, R.S.; Odedara, R.; Kalaria, R.I.; Upadhyay, J.J. Synthesis, characterization and antimicrobial activity of new quinazolin- 4(3H)-one schiff base derivatives. J. Chem. Pharm. Res., 2012, 4, 4864-4869.
[60]
Shi, L.P.; Jiang, K.M.; Jiang, J.J.; Jin, Y.; Tao, Y.H.; Li, K.; Wang, X.H.; Lin, J. Synthesis and antimicrobial activity of polyhalobenzonitrile quinazolin-4(3H)-one derivatives. Bioorg. Med. Chem. Lett., 2013, 23(21), 5958-5963.
[http://dx.doi.org/10.1016/j.bmcl.2013.08.068] [PMID: 24044873]
[61]
Desai, N.C.; Dodiya, A.; Shihory, N. Synthesis and antimicrobial activity of novel quinazolinone–thiazolidine–quinoline compounds. J. Saudi Chem. Soc., 2013, 17(3), 259-267.
[http://dx.doi.org/10.1016/j.jscs.2011.04.001]
[62]
Rajasekaran, A.; Rajamanickam, V.; Darlinquine, S. Synthesis of some new thioxoquinazolinone derivatives and a study on their anticonvulsant and antimicrobial activities. Eur. Rev. Med. Pharmacol. Sci., 2013, 17(1), 95-104.
[PMID: 23329529]
[63]
Al-Omary, F.A.M.; Hassan, G.S.; El-Messery, S.M.; Nagi, M.N.; Habib, E.S.E.; El-Subbagh, H.I. Nonclassical antifolates, part 3: Synthesis, biological evaluation and molecular modeling study of some new 2-heteroarylthio-quinazolin-4-ones. Eur. J. Med. Chem., 2013, 63, 33-45.
[http://dx.doi.org/10.1016/j.ejmech.2012.12.061] [PMID: 23454532]
[64]
Ghorab, M.M.; Ismail, Z.H.; Radwan, A.A.; Abdalla, M. Synthesis and pharmacophore modeling of novel quinazolines bearing a biologically active sulfonamide moiety. Acta Pharm., 2013, 63(1), 1-18.
[http://dx.doi.org/10.2478/acph-2013-0006] [PMID: 23482309]
[65]
Akbari, V.K.; Savaliya, P.P.; Patel, K.C. Synthesis and antimicrobial activity of 2-substituted-3-((3-(6-Nitrobenzo[ D ]thiazol-2-yl)-4-oxo-3,4-Dihydroquinazolin-2-yl)Methyl)-1,3,4-thiadiazol-3-ium-5-thiolate. Phosphorus Sulfur Silicon Relat. Elem., 2014, 189(5), 711-719.
[http://dx.doi.org/10.1080/10426507.2013.829839]
[66]
Rajasekhar, K.K.; Nizamuddin, D.; Surur, A.S.; Mekonnen, Y.T. Synthesis, characterization, antitubercular and antibacterial activity, and molecular docking of 2,3-disubstituted quinazolinone derivatives. Res. Rep. Med. Chem., 2016, 6, 15-26.
[67]
Kapoor, B.; Nabi, A.; Gupta, R.; Gupta, M. Synthesis and antimicrobial evaluation of quinazolinone peptide derivatives. Asian J. Pharm. Clin. Res., 2017, 10(16), 7-12.
[http://dx.doi.org/10.22159/ajpcr.2017.v10s4.21329]
[68]
Hamel, E.; Lin, C.M.; Plowman, J.; Wang, H.K.; Lee, K.H.; Paull, K.D. Antitumor 2,3-dihydro-2-(aryl)-4(1H)-quinazolinone derivatives. Interactions with tubulin. Biochem. Pharmacol., 1996, 51(1), 53-59.
[http://dx.doi.org/10.1016/0006-2952(95)02156-6] [PMID: 8534268]
[69]
Kinoshita, T.; Nakanishi, I.; Warizaya, M.; Iwashita, A.; Kido, Y.; Hattori, K.; Fujii, T. Inhibitor-induced structural change of the active site of human poly(ADP-ribose) polymerase. FEBS Lett., 2004, 556(1-3), 43-46.
[http://dx.doi.org/10.1016/S0014-5793(03)01362-0] [PMID: 14706823]
[70]
Raffa, D.; Daidone, G.; Maggio, B.; Cascioferro, S.; Plescia, F.; Schillaci, D. Synthesis and antileukemic activity of new 3-(5-methylisoxazol-3-yl) and 3-(pyrimidin-2-yl)-2-styrylquinazolin-4(3H)-ones. Farmaco, 2004, 59(6), 451-455.
[http://dx.doi.org/10.1016/j.farmac.2003.10.006] [PMID: 15178307]
[71]
Raffa, D.; Edler, M.C.; Daidone, G.; Maggio, B.; Merickech, M.; Plescia, S.; Schillaci, D.; Bai, R.; Hamel, E. Synthesis, cytotoxicity, and inhibitory effects on tubulin polymerization of a new 3-heterocyclo substituted 2-styrylquinazolinones. Eur. J. Med. Chem., 2004, 39(4), 299-304.
[http://dx.doi.org/10.1016/j.ejmech.2003.12.009] [PMID: 15072839]
[72]
Govindaraj, Y.; Sathyamoorthy, V.; Karthikeyan, V.; Melanaphuru, V.; Agrahari, V.; Gupta, S.; Nema, R.K. Synthesis and in-vivo anticancer screening of 2-{[bis-(2-chloroethyl) amino] methyl}-6, 8-dinitro-1- (4-substituted ethyl)-1h-quinazolin-4-one derivatives. Acad. J. Cancer Res., 2009, 2, 73-77.
[73]
Al-Obaid, A.M.; Abdel-Hamide, S.G.; El-Kashef, H.A.; Abdel-Aziz, A.A.M.; El-Azab, A.S.; Al-Khamees, H.A.; El-Subbagh, H.I. Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4(3H)-quinazolinone analogs. Eur. J. Med. Chem., 2009, 44(6), 2379-2391.
[http://dx.doi.org/10.1016/j.ejmech.2008.09.015] [PMID: 18950904]
[74]
Abdel Gawad, N.M.; Georgey, H.H.; Youssef, R.M.; El-Sayed, N.A. Synthesis and antitumor activity of some 2, 3-disubstituted quinazolin-4(3H)-ones and 4, 6- disubstituted- 1, 2, 3, 4-tetrahydroquinazolin-2H-ones. Eur. J. Med. Chem., 2010, 45(12), 6058-6067.
[http://dx.doi.org/10.1016/j.ejmech.2010.10.008] [PMID: 21051122]
[75]
Al-Omary, F.A.M.; Abou-zeid, L.A.; Nagi, M.N.; Habib, E.S.E.; Abdel-Aziz, A.A.M.; El-Azab, A.S.; Abdel-Hamide, S.G.; Al-Omar, M.A.; Al-Obaid, A.M.; El-Subbagh, H.I. Non-classical antifolates. Part 2: Synthesis, biological evaluation, and molecular modeling study of some new 2,6-substituted-quinazolin-4-ones. Bioorg. Med. Chem., 2010, 18(8), 2849-2863.
[http://dx.doi.org/10.1016/j.bmc.2010.03.019] [PMID: 20350811]
[76]
Noolvi, M.N.; Patel, H.M.; Bhardwaj, V.; Chauhan, A. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: Search for anticancer agent. Eur. J. Med. Chem., 2011, 46(6), 2327-2346.
[http://dx.doi.org/10.1016/j.ejmech.2011.03.015] [PMID: 21458891]
[77]
Wani, Z.A.; Pathania, A.S.; Mahajan, G.; Behl, A.; Mintoo, M.J.; Guru, S.K.; Viswanath, A.; Malik, F.; Kamal, A.; Mondhe, D.M. Anticancer activity of a novel quinazolinone-chalcone derivative through cell cycle arrest in pancreatic cancer cell line. J. Solid Tumors, 2015, 5(2), 73-85.
[http://dx.doi.org/10.5430/jst.v5n2p73]
[78]
Hosseinzadeh, L.; Aliabadi, A.; Rahnama, M.; Sadeghi, H.M.; Khajouei, M. Synthesis and cytotoxic evaluation of some new 3-(2-(2-phenylthiazol-4-yl) ethyl)-quinazolin-4(3H) one derivatives with potential anticancer effects. Res. Pharm. Sci., 2017, 12(4), 290-298.
[http://dx.doi.org/10.4103/1735-5362.212046] [PMID: 28855940]
[79]
Abuelizz, H.A.; Marzouk, M.; Ghabbour, H.; Al-Salahi, R. Synthesis and anticancer activity of new quinazoline derivatives. Saudi Pharm. J., 2017, 25(7), 1047-1054.
[http://dx.doi.org/10.1016/j.jsps.2017.04.022] [PMID: 29158714]
[80]
El-Sayed, S.; Metwally, K.; El-Shanawani, A.A.; Abdel-Aziz, L.M.; Pratsinis, H.; Kletsas, D. Synthesis and anticancer activity of novel quinazolinone-based rhodanines. Chem Cent J., 2017, 11, 102.
[http://dx.doi.org/10.1186/s13065-017-0333-x]
[81]
Hassanzadeh, F.; Poorirani, S.; Sadeghian-Rizi, S.; Khodarahmi, G.; Khajouei, M.R. Synthesis and cytotoxic evaluation of novel quinazolinone derivatives as potential anticancer agents. Res. Pharm. Sci., 2018, 13(5), 450-459.
[http://dx.doi.org/10.4103/1735-5362.236838] [PMID: 30271447]
[82]
Dohle, W.; Jourdan, F.L.; Menchon, G.; Prota, A.E.; Foster, P.A.; Mannion, P.; Hamel, E.; Thomas, M.P.; Kasprzyk, P.G.; Ferrandis, E.; Steinmetz, M.O.; Leese, M.P.; Potter, B.V.L. Quinazolinone-based anticancer agents: Synthesis, antiproliferative SAR, antitubulin activity, and tubulin co-crystal structure. J. Med. Chem., 2018, 61(3), 1031-1044.
[http://dx.doi.org/10.1021/acs.jmedchem.7b01474] [PMID: 29227648]
[83]
Hassanzadeh, F.; Sadeghi-aliabadi, H.; Nikooei, S.; Jafari, E.; Vaseghi, G. Synthesis and cytotoxic evaluation of some derivatives of triazolequinazolinone hybrids. Res. Pharm. Sci., 2019, 14(2), 130-137.
[http://dx.doi.org/10.4103/1735-5362.253360] [PMID: 31620189]
[84]
Faghih, Z.; Rahmannejadi, N.; Sabet, R.; Zomorodian, K.; Asad, M.; Khabnadideh, S. Synthesis of some novel dibromo-2-arylquinazolinone derivatives as cytotoxic agents. Res. Pharm. Sci., 2019, 14(2), 115-121.
[http://dx.doi.org/10.4103/1735-5362.253358] [PMID: 31620187]
[85]
Deshineni, R.; G, A.C.; Banothu, J.; Velpula, R.; Chellamella, G. Synthesis, anticancer and antibacterial evaluation of novel 1,3-disubstituted-1H-pyrazole-4-yl-methylene embedded fused thiazolo[2,3-b]quinazolinones. Chem. Data Collect., 2020, 30, 100546.
[http://dx.doi.org/10.1016/j.cdc.2020.100546]
[86]
Kumar, P.; Dhawan, K.N.; Vrat, S.; Bhargava, K.P.; Kishore, K. Synthesis of 6-substituted 2-phenyl-3-(5-substituted mercapto-1,3,4, thiadiazol-2-yl)quinazolin-4-(3H)-ones as antitubercular agents. Arch. Pharm. (Weinheim), 1983, 316(9), 759-763.
[http://dx.doi.org/10.1002/ardp.19833160906] [PMID: 6416222]
[87]
Omar, A.; Ahmed, M.A. Synthesis of some new 3H-quinazolin-4-one derivatives as potential antitubercular agents. World Appl. Sci. J., 2008, 5, 94-99.
[88]
Chaudhary, M.; Bhattacharya, S.; Ahmad, Y. Design and synthesis of quinazolinone derivatives as a novel antitubercular agents. Pharm. Lett., 2012, 4, 954-960.
[89]
Sivakumar, K.K.; Rajasekharan, A.; Rao, R.; Narasimhan, B. Synthesis, SAR study and evaluation of Mannich and Schiff bases of pyrazol-5(4H)-one moiety containing 3-(hydrazinyl)-2-phenylquinazolin-4(3H)-one. Indian J. Pharm. Sci., 2013, 75(4), 463-475.
[http://dx.doi.org/10.4103/0250-474X.119832] [PMID: 24302802]
[90]
Tran, A.T.; Wen, D.; West, N.P.; Baker, E.N.; Britton, W.J.; Payne, R.J. Inhibition studies on Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase (GlmU). Org. Biomol. Chem., 2013, 11(46), 8113-8126.
[http://dx.doi.org/10.1039/c3ob41896k] [PMID: 24158720]
[91]
Rakesh, K.P.; Darshini, N.; Shubhavathi, T.; Mallesha, N. Biological applications of quinazolinone analogues: A review. OMCIJ, 2017, 2(2), 555585.
[92]
Babu, R.R.; Naresh, K.; Ravi, A.; Madhava Reddy, B.; Harinadha Babu, V. Synthesis of novel isoniazid incorporated styryl quinazolinones as anti-tubercular agents against INH sensitive and MDR M. tuberculosis strains. Med. Chem. Res., 2014, 23(10), 4414-4419.
[http://dx.doi.org/10.1007/s00044-014-1020-2]
[93]
Subramaniam, R.; Rao, G.; Jaiswal, P.K. Synthesis of some 2,3-disubstituted quinazolinone derivatives as antitubercular and antibacterial activity agents. Pharm. Sin., 2014, 5, 37-40.
[94]
Lu, W.; Baig, I. A.; Sun, H. J.; Cui, C. J.; Guo, R.; In-Pil Jung, D. Synthesis, crystal structure and biological evaluation of substituted quinazolinone benzoates as novel antituberculosis agents targeting acetohydroxyacid synthase. Eur. J. Med. Chem., 2015, 94, 298-305.
[95]
Couturier, C.; Lair, C.; Pellet, A.; Upton, A.; Kaneko, T.; Perron, C.; Cogo, E.; Menegotto, J.; Bauer, A.; Scheiper, B.; Lagrange, S.; Bacqué, E. Identification and optimization of a new series of anti-tubercular quinazolinones. Bioorg. Med. Chem. Lett., 2016, 26(21), 5290-5299.
[http://dx.doi.org/10.1016/j.bmcl.2016.09.043] [PMID: 27671498]
[96]
Akram, Md.; Sayeed, A.; Salaam, S.S.A. Studies on the design, synthesis and antitubercular activity of some new quinazolinone derivatives. Indo. Am. J. P. Sci, 2018, 05, 1915-1925.
[97]
Sen, T.; Neog, K.; Sarma, S.; Manna, P.; Deka Boruah, H.P.; Gogoi, P.; Singh, A.K. Efflux pump inhibition by 11H-pyrido[2,1-b]quinazolin-11-one analogues in mycobacteria. Bioorg. Med. Chem., 2018, 26(17), 4942-4951.
[http://dx.doi.org/10.1016/j.bmc.2018.08.034] [PMID: 30190182]
[98]
Murugesan, D.; Ray, P.C.; Bayliss, T.; Prosser, G.A.; Harrison, J.R.; Green, K.; Soares de Melo, C.; Feng, T.S.; Street, L.J.; Chibale, K.; Warner, D.F.; Mizrahi, V.; Epemolu, O.; Scullion, P.; Ellis, L.; Riley, J.; Shishikura, Y.; Ferguson, L.; Osuna-Cabello, M.; Read, K.D.; Green, S.R.; Lamprecht, D.A.; Finin, P.M.; Steyn, A.J.C.; Ioerger, T.R.; Sacchettini, J.; Rhee, K.Y.; Arora, K.; Barry, C.E., III; Wyatt, P.G.; Boshoff, H.I.M. 2-Mercapto-quinazolinones as inhibitors of type II NADH dehydrogenase and Mycobacterium tuberculosis : Structure-activity relationships, mechanism of action and absorption, distribution, metabolism, and excretion characterization. ACS Infect. Dis., 2018, 4(6), 954-969.
[http://dx.doi.org/10.1021/acsinfecdis.7b00275] [PMID: 29522317]
[99]
Anil, S.M.; Shobith, R.; Kiran, K.R.; Swaroop, T.R.; Mallesha, N.; Sadashiva, M.P. Facile synthesis of 1,4-benzodiazepine-2,5-diones and quinazolinones from amino acids as anti-tubercular agents. New J. Chem., 2019, 43(1), 182-187.
[http://dx.doi.org/10.1039/C8NJ04936J]
[100]
Neha Krishnarth; Anurag; Chaudhary, A.; Verma, S.K. Quinazolinone novel derivatives synthesis and their biological evaluation as antimicrobial and antitubercular agents. Int. J. Res. Pharmaceut. Sci., 2019, 10(4), 3026-3034.
[http://dx.doi.org/10.26452/ijrps.v10i4.1590]
[101]
Yadav, M.K.; Tripathi, L.; Goswami, D. Evaluation of anticonvulsant activity and toxicity screening of semicarbazones derived from quinazolinone scaffold. Curr. Bioact. Compd., 2019, 15(5), 573-581.
[http://dx.doi.org/10.2174/1573407214666180710143557]
[102]
Wolfe, J.F.; Rathman, T.L.; Sleevi, M.C.; Campbell, J.A.; Greenwood, T.D. Synthesis and anticonvulsant activity of some new 2-substituted 3-aryl-4(3H)-quinazolinones. J. Med. Chem., 1990, 33(1), 161-166.
[http://dx.doi.org/10.1021/jm00163a027] [PMID: 2296016]
[103]
Usifoh, C.O.; Scriba, G.K.E. Synthesis and anticonvulsant activity of acetylenic quinazolinone derivatives. Arch. Pharm. (Weinheim), 2000, 333(8), 261-266.
[http://dx.doi.org/10.1002/1521-4184(20008)333:8<261::AID-ARDP261>3.0.CO;2-O] [PMID: 11008376]
[104]
Georgey, H.; Abdel-Gawad, N.; Abbas, S. Synthesis and anticonvulsant activity of some quinazolin-4-(3H)-one derivatives. Molecules, 2008, 13(10), 2557-2569.
[http://dx.doi.org/10.3390/molecules13102557] [PMID: 18927518]
[105]
Jatav, V.; Mishra, P.; Kashaw, S.; Stables, J.P. Synthesis and CNS depressant activity of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H )-ones. Eur J Med Chem, 2008, 43, 135-141.
[106]
Kashaw, S.K.; Kashaw, V.; Mishra, P.; Jain, N.K.; Stables, J.P. Synthesis, anticonvulsant and CNS depressant activity of some new bioactive 1-(4-substituted-phenyl)-3-(4-oxo-2-phenyl/ethyl-4H-quinazolin-3-yl)-urea. Eur. J. Med. Chem., 2009, 44(11), 4335-4343.
[http://dx.doi.org/10.1016/j.ejmech.2009.05.008] [PMID: 19674817]
[107]
Ilangovan, P.; Ganguly, S.; Pandi, V. Design and synthesis of novel quinazolinone derivatives as broad spectrum anticonvulsant and antimicrobial agent. J. Pharm. Res., 2010, 3, 703-706.
[108]
El-Azab, A.S.; Abdel-Hamide, S.G.; Sayed-Ahmed, M.M.; Hassan, G.S.; El-Hadiyah, T.M.; Al-Shabanah, O.A.; Al-Deeb, O.A.; El-Subbagh, H.I. Novel 4(3H)-quinazolinone analogs: Synthesis and anticonvulsant activity. Med. Chem. Res., 2013, 22(6), 2815-2827.
[http://dx.doi.org/10.1007/s00044-012-0280-y]
[109]
Zayed, M.F.; Ahmed, H.E.A.; Omar, A.S.M.; Abdelrahim, A.S.; El-Adl, K. Design, synthesis, and biological evaluation studies of novel quinazolinone derivatives as anticonvulsant agents. Med. Chem. Res., 2013, 22(12), 5823-5831.
[http://dx.doi.org/10.1007/s00044-013-0569-5]
[110]
Zayed, M.F. New fluorinated quinazolinone derivatives as anticonvulsant agents. J. Taibah Univ. Med. Sci., 2014, 9(2), 104-109.
[http://dx.doi.org/10.1016/j.jtumed.2013.11.009]
[111]
Nerkar, A.G.; Sahu, M.; Valvi, S.; Sawant, S.D. In silico design, synthesis and pharmacological screening of quinazolinones as NMDA receptor antagonists for Anticonvulsant activity: Part II. J. Young Pharm., 2015, 7(4), 303-310.
[http://dx.doi.org/10.5530/jyp.2015.4.4]
[112]
Patel, H.M.; Noolvi, M.N.; Shirkhedkar, A.A.; Kulkarni, A.D.; Pardeshi, C.V.; Surana, S.J. Anti-convulsant potential of quinazolinones. RSC Adv., 2016, 6(50), 44435-44455.
[http://dx.doi.org/10.1039/C6RA01284A]
[113]
Noureldin, N.A.; Kothayer, H.; Lashine, E-S.M.; Baraka, M.M.; El-Eraky, W.; Awdan, S.A.E. Synthesis, anticonvulsant activity, and SAR study of novel 4-quinazolinone derivatives. Arch. Pharm. (Weinheim), 2017, 350(2), 1600332.
[http://dx.doi.org/10.1002/ardp.201600332]
[114]
Achana, S. Synthesis and evaluation of some newer thiazolidinonyl substituted quinazolinones as potent anticonvulsant agents. Int. J. Chemtech Res., 2018, 11, 09-16.
[115]
Kurogi, Y.; Inoue, Y.; Tsutsumi, K.; Nakamura, S.; Nagao, K.; Yoshitsugu, H.; Tsuda, Y. Synthesis and hypolipidemic activities of novel 2-[4-[diethoxyphosphoryl)methyl]phenyl]quinazolines and 4(3H)-quinazolinones. J. Med. Chem., 1996, 39(7), 1433-1437.
[http://dx.doi.org/10.1021/jm9506938] [PMID: 8691473]
[116]
Kathiravan, M.K.; Vidyasagar, N.; Khiste, R.; Chote, A.; Jain, K. Synthesis and antihyperlipidemic activity of some novel 4-substituted-2-substitutedmethyltriazino[6,1-b]quinazolin-10-ones and 2,4-disubstituted-6,7-dimethoxy quinazoline. Arab. J. Chem., 2016, 9, S395-S403.
[http://dx.doi.org/10.1016/j.arabjc.2011.05.009]
[117]
Büyüktimkin, S.; Buschauer, A.; Schunack, W. Quinazolinones. 18. Synthesis and H1/H2-antihistaminic action of omega-[2-aryl-2,3-dihydro-4(1H)-quinazolinone-1-yl]alkyl substituted ureas and cyanoguanidines. Arch. Pharm. (Weinheim), 1991, 324(5), 291-295.
[http://dx.doi.org/10.1002/ardp.19913240507] [PMID: 1679625]
[118]
Raju, M.B.; Raja Sekhar, K.K.; Prasanthi, G. Synthesis and H1-Antihistaminic activity of some 3-[(N,N-dialkylamino)alkyl]-6-halo-2-thio-4(3H)-quinazolinones. J. Pharm. Res., 2010, 3, 2628-2630.
[119]
Dinakaran, M.; Selvam, P.; DeClercq, E.; Sridhar, S.K. Synthesis, antiviral and cytotoxic activity of 6-bromo-2,3-disubstituted-4(3H)-quinazolinones. Biol. Pharm. Bull., 2003, 26(9), 1278-1282.
[http://dx.doi.org/10.1248/bpb.26.1278] [PMID: 12951471]
[120]
Selvam, P.; Vijayalakshimi, P.; Smee, D.F.; Gowen, B.B.; Julander, J.G.; Day, C.W.; Barnard, D.L. Novel 3-sulphonamidoquinazolin-4(3H)-one derivatives: Microwave-assisted synthesis and evaluation of antiviral activities against respiratory and biodefense viruses. Antivir. Chem. Chemother., 2007, 18(5), 301-305.
[http://dx.doi.org/10.1177/095632020701800506] [PMID: 18046963]
[121]
Liu, S.; Wang, W.; Jiang, L.; Wan, S.; Zhang, L.; Yu, R.; Jiang, T. 2-Pyridinyl-4(3H)-Quinazolinone: A scaffold for anti-influenza A virus compounds. Chem. Biol. Drug Des., 2015, 86(5), 1221-1225.
[http://dx.doi.org/10.1111/cbdd.12589]
[122]
Abbas, S.Y.; El-Bayouki, K.A.M.; Basyouni, W.M.; Mostafa, E.A. New series of 4(3H)-quinazolinone derivatives: Syntheses and evaluation of antitumor and antiviral activities. Med. Chem. Res., 2018, 27(2), 571-582.
[http://dx.doi.org/10.1007/s00044-017-2083-7]
[123]
Terashima, K.; Shimamura, H.; Kawase, A.; Tanaka, Y.; Tanimura, T.; Kamisaki, T.; Ishizuka, Y.; Sato, M. Studies on antiulcer agents. IV. Antiulcer effects of 2-benzylthio-5,6,7,8-tetrahydro-4(3H)-quinazolinones and related compounds. Chem. Pharm. Bull. (Tokyo), 1995, 43(11), 2021-2023.
[http://dx.doi.org/10.1248/cpb.43.2021] [PMID: 8575039]
[124]
Patil, A.; Ganguly, S.; Surana, S. Synthesis and antiulcer activity of 2-[5-substituted-1-H-benzo(d) imidazol-2-yl sulfinyl]methyl-3-substituted quinazoline-4-(3H) ones. J. Chem. Sci., 2010, 122(3), 443-450.
[http://dx.doi.org/10.1007/s12039-010-0052-5]
[125]
Muh’d, M.; Uzairu, A.; Shallangwa, G.A.; Uba, S. Molecular docking and quantitative structure-activity relationship study of anti-ulcer activity of quinazolinone derivatives. J. King Saud Univ. Sci., 2020, 32(1), 657-666.
[http://dx.doi.org/10.1016/j.jksus.2018.10.003]
[126]
Al-Omar, M.; El-Azab, A.S.; El-Obeid, H.; Abdel Hamide, S. Synthesis of some new 4-(3H)- quinazoline analogs as potential antioxidant agents. J. Saudi Chem. Soc., 2006, 10, 113-130.
[127]
Karumanchi, A.; Devi, M. Synthesis and screening of 3-(1, 2-dihydro-1-substituted-2- oxopyrrolo [2, 3-b] pyridin-3-ylideneamino)-2-(substituted)- quinazolin-4(3H)-. Ones. Int. J. Drug Dev. & Res., 2014, 6, 259-268.
[128]
Bouley, R.; Ding, D.; Peng, Z.; Bastian, M.; Lastochkin, E.; Song, W.; Suckow, M.A.; Schroeder, V.A.; Wolter, W.R.; Mobashery, S.; Chang, M. Structure-activity relationship for the 4 (3 H)-Quinazolinone antibacterials. J. Med. Chem., 2016, 59(10), 5011-5021.
[http://dx.doi.org/10.1021/acs.jmedchem.6b00372] [PMID: 27088777]
[129]
Brown, C.E.; Kong, T.; McNulty, J.; D’Aiuto, L.; Williamson, K.; McClain, L.; Piazza, P.; Nimgaonkar, V.L. Discovery of potent antiviral (HSV-1) quinazolinones and initial structure-activity relationship studies. Bioorg. Med. Chem. Lett., 2017, 27(20), 4601-4605.
[http://dx.doi.org/10.1016/j.bmcl.2017.09.026] [PMID: 28943043]
[130]
Peng, J.W.; Yin, X.D.; Li, H.; Ma, K.Y.; Zhang, Z.J.; Zhou, R.; Wang, Y.L.; Hu, G.F.; Liu, Y.Q. Design, synthesis, and structure-activity relationship of quinazolinone derivatives as potential fungicides. J. Agric. Food Chem., 2021, 69(16), 4604-4614.
[http://dx.doi.org/10.1021/acs.jafc.0c05475] [PMID: 33872004]
[131]
Laleu, B.; Akao, Y.; Ochida, A.; Duffy, S.; Lucantoni, L.; Shackleford, D.M.; Chen, G.; Katneni, K.; Chiu, F.C.K.; White, K.L.; Chen, X.; Sturm, A.; Dechering, K.J.; Crespo, B.; Sanz, L.M.; Wang, B.; Wittlin, S.; Charman, S.A.; Avery, V.M.; Cho, N.; Kamaura, M. Discovery and structure–activity relationships of quinazolinone-2-carboxamide derivatives as novel orally efficacious antimalarials. J. Med. Chem., 2021, 64(17), 12582-12602.
[http://dx.doi.org/10.1021/acs.jmedchem.1c00441] [PMID: 34437804]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy